288 related articles for article (PubMed ID: 34220923)
1. A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Zhang Y; Chen P; Zhou Q; Wang H; Hua Q; Wang J; Zhong H
Front Genet; 2021; 12():570336. PubMed ID: 34220923
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
[TBL] [Abstract][Full Text] [Related]
3. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z
Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624
[TBL] [Abstract][Full Text] [Related]
4. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
5. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
Yang J; Xie K; Li C
Life Sci; 2020 Sep; 256():117906. PubMed ID: 32504750
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.
Li SR; Man QW; Liu B
Front Oncol; 2022; 12():943945. PubMed ID: 36452497
[TBL] [Abstract][Full Text] [Related]
7. Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma.
Huang C; Liang Y; Dong Y; Huang L; Li A; Du R; Huang H
Front Cell Dev Biol; 2022; 10():884590. PubMed ID: 36081907
[No Abstract] [Full Text] [Related]
8. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive immunogenomic landscape analysis of prognosis-related genes in head and neck cancer.
Li L; Wang XL; Lei Q; Sun CZ; Xi Y; Chen R; He YW
Sci Rep; 2020 Apr; 10(1):6395. PubMed ID: 32286381
[TBL] [Abstract][Full Text] [Related]
11. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
Qiu Y; Cui L; Lin Y; Gao B; Li J; Zhao X; Zhu X; Hu S; Lin L
Front Oncol; 2020; 10():1502. PubMed ID: 33224866
[TBL] [Abstract][Full Text] [Related]
14. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
Front Genet; 2022; 13():1085700. PubMed ID: 36579330
[No Abstract] [Full Text] [Related]
15. Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma.
Hu Z; Zhou J; Li Y; Luan Y; Li H; Jia B; Xie Z; Cheng B; Wu T
Front Immunol; 2022; 13():915207. PubMed ID: 36148222
[TBL] [Abstract][Full Text] [Related]
16. Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma.
Lu Y; Jia Z
Int J Gen Med; 2022; 15():4793-4805. PubMed ID: 35592543
[TBL] [Abstract][Full Text] [Related]
17. Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma.
She Y; Kong X; Ge Y; Yin P; Liu Z; Chen J; Gao F; Fang S
Cancer Cell Int; 2020; 20():22. PubMed ID: 31988638
[TBL] [Abstract][Full Text] [Related]
18. Identification of an immune-related signature as a prognostic classifier for patients with early-stage head and neck squamous cell carcinoma.
Wang L; Zhang Y; Li H; Peng J; Gao C; Yu Q; Gao P; Li L; Chen K; Ye F
Transl Cancer Res; 2024 Mar; 13(3):1367-1381. PubMed ID: 38617526
[TBL] [Abstract][Full Text] [Related]
19. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
Front Oncol; 2022; 12():857994. PubMed ID: 35619896
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes.
Peng G; Chi H; Gao X; Zhang J; Song G; Xie X; Su K; Song B; Yang J; Gu T; Li Y; Xu K; Li H; Liu Y; Tian G
Front Genet; 2022; 13():1010044. PubMed ID: 36406133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
